A Phase 1/2 Study of GW5282 in Participants With Advanced Solid Tumors

NCT07328217 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

203

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: GW5282
DRUG: GW5282

Sponsor

Dizal Pharmaceuticals